Detalles de la búsqueda
1.
No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That Are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: A Meta-analysis.
Clin Gastroenterol Hepatol
; 19(4): 668-679.e8, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32629124
2.
Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn's Disease.
Clin Gastroenterol Hepatol
; 18(10): 2256-2261, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31743755
3.
Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort.
Cancer Med
; 12(5): 5341-5351, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394147
4.
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Dig Liver Dis
; 55(4): 541-548, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36115817
5.
Positive histologic margins is a risk factor of recurrence after ileocaecal resection in Crohn's disease.
Clin Res Hepatol Gastroenterol
; 45(5): 101569, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33199239
6.
Inflammatory bowel disease symptoms at the time of anal fistula lead to the diagnosis of Crohn's disease.
Clin Res Hepatol Gastroenterol
; 44(6): 968-972, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32336615
7.
Premedication as primary prophylaxis does not influence the risk of acute infliximab infusion reactions in immune-mediated inflammatory diseases: A systematic review and meta-analysis.
Dig Liver Dis
; 51(4): 484-488, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30686715
Resultados
1 -
7
de 7
1
Próxima >
>>